戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 l.) species complex are known to cause human Lyme borreliosis.
2 nvolved in pathogenic processes operative in Lyme borreliosis.
3 may be useful for the serodiagnosis of early Lyme borreliosis.
4  role of complement in the global ecology of Lyme borreliosis.
5 borne diseases should prompt a fresh look at Lyme borreliosis.
6 h2 cells in the genetic resistance to murine Lyme borreliosis.
7  the early stages of tick-transmitted murine Lyme borreliosis.
8 seroprevalence of HGE was similar to that of Lyme borreliosis.
9  for monitoring the response to treatment of Lyme borreliosis.
10 ri can prevent infection in animal models of Lyme borreliosis.
11 % CI=1.18, 2.58) compared with those without Lyme borreliosis.
12  examine rates of mental disorders following Lyme borreliosis.
13 nd vector for infectious diseases, including Lyme borreliosis.
14 f the varying manifestations associated with Lyme borreliosis.
15 ochetes' evasion of macrophages during early Lyme borreliosis.
16 lian host as part of the disease process for Lyme borreliosis.
17 and 81 control subjects without a history of Lyme borreliosis.
18 variations in the clinical manifestations of Lyme borreliosis.
19 tant in the murine model of tick-transmitted Lyme borreliosis.
20  prospective studies using a murine model of Lyme borreliosis.
21 and joint histopathology during experimental Lyme borreliosis.
22  for patients with localized or disseminated Lyme borreliosis.
23 re essential for persistence associated with Lyme borreliosis.
24  burgdorferi infection in the mouse model of Lyme borreliosis.
25 le vaccine candidate to help protect against Lyme borreliosis.
26 elated to Borrelia burgdorferi, the agent of Lyme borreliosis.
27 protect mice from experimental syringe-borne Lyme borreliosis.
28 t hypervariability among isolates that cause Lyme borreliosis.
29                          Of 96 patients with Lyme borreliosis, 9 (9.4%) demonstrated immunoserologic
30 on between the chronic skin manifestation of Lyme borreliosis, acrodermatitis chronica atrophicans, a
31 . burgdorferi sensu lato genospecies causing Lyme borreliosis across Eurasia.
32 feri (Bb) sensu lato, the etiologic agent of Lyme borreliosis, adapts to distinct environments in the
33                                              Lyme borreliosis affects the nervous system in three pri
34 ecover a viable RecA-deficient mutant of the Lyme borreliosis agent Borrelia burgdorferi, we characte
35 h a range of early or late manifestations of Lyme borreliosis and found that only American patients w
36 ignancy more often had signs of disseminated Lyme borreliosis and more frequently needed antibiotic r
37 ovide insight into mechanisms of immunity to Lyme borreliosis and other vector-borne diseases.
38 nes are induced by spirochetes during murine Lyme borreliosis and play roles in protective immunity.
39 r of human infectious diseases, most notably Lyme borreliosis and tick-borne encephalitis virus.
40 ucial to the transmission and persistence of Lyme borreliosis and tick-borne relapsing fever.
41 s potential relevance to the pathogenesis of Lyme borreliosis and to the physiology of the spirochete
42 e the virulence of Bb in the murine model of Lyme borreliosis and was essential for the persistence o
43 respectively by B. burgdorferi, the agent of Lyme borreliosis, and B. hermsii, the agent of tick-born
44 f autochthonous transmission of the agent of Lyme borreliosis, and continued monitoring of exposure r
45  neuroborreliosis, which with non-neurologic Lyme borreliosis, and which with neither.
46 ri sensu lato spirochetes (Borrelia) causing Lyme borreliosis are able to disseminate from the initia
47 sensu lato known to be associated with human Lyme borreliosis (B. burgdorferi sensu stricto, B. garin
48 Borrelia are known to be causative agents of Lyme borreliosis: B. burgdorferi sensu stricto, B. garin
49 timulatory molecules on the course of murine Lyme borreliosis because experimental Lyme arthritis is
50 sed lipoproteins of relapsing fever (RF) and Lyme borreliosis Borrelia spirochetes mediate certain in
51 roteins are essential to the pathogenesis of Lyme borreliosis, but the mechanisms responsible for the
52 ary quality has clouded our understanding of Lyme borreliosis by giving Borrelia burgdorferi infectio
53  of IL-17 in the development of experimental Lyme borreliosis by infecting C3H mice devoid of the com
54 eri, the tick-transmitted etiologic agent of Lyme borreliosis, can colonize and persist in multiple t
55 ectious diseases are reviewed: tuberculosis, Lyme borreliosis, cat scratch disease, toxocariasis, con
56                                       Murine Lyme borreliosis, caused by infection with the spirochet
57                                              Lyme borreliosis, caused by the tick-borne bacterium Bor
58 e the role of B. burgdorferi-specific Abs in Lyme borreliosis, CD40 ligand-deficient (CD40L-deficient
59 relia burgdorferi, a spirochaete that causes Lyme borreliosis, contains 21 linear and circular plasmi
60  that myositis can be a prominent feature of Lyme borreliosis depending on the infecting organism and
61 f 5, 100%) and patients (31 of 43, 72%) with Lyme borreliosis developed P35 or P37 antibodies.
62                                              Lyme borreliosis differs in dogs and humans in terms of
63 e causative agents of the tick-borne disease Lyme borreliosis, disseminate hematogenously from the ti
64                The clinical presentations of Lyme borreliosis do differ in North America and Eurasia,
65 e infections in the United States other than Lyme borreliosis, emphasizing a clinical and geographic
66 are addressed using examples from tick-borne Lyme borreliosis; flea-borne plague; and mosquito-borne
67 ythema migrans skin lesions of patients with Lyme borreliosis from the United States or Slovenia.
68 naming this new South American member of the Lyme borreliosis group B. chilensis VA1 in honor of its
69 s spirochete as a new genospecies within the Lyme borreliosis group.
70 amples from patients with case-defined early Lyme borreliosis had anti-B. burgdorferi sensu stricto 5
71                             Individuals with Lyme borreliosis had higher rates of any mental disorder
72        The serious morbidity associated with Lyme borreliosis has focused considerable effort on the
73  block pathogen spread and eventually reduce Lyme borreliosis health burden.
74 viduals with confirmed clinical diagnoses of Lyme borreliosis, immunoblotting is still advised as an
75 fect of anti-interleukin (IL-12 treatment on Lyme borreliosis in C3H/HeN (C3H) mice was assessed beca
76 he specificity of the serologic diagnosis of Lyme borreliosis in cases of acute facial palsy.
77 o is the only established etiologic agent of Lyme borreliosis in dogs and in humans in North America.
78 itical for accurate surveillance of TBRF and Lyme borreliosis in dogs.
79 immunity could therefore potentially prevent Lyme borreliosis in humans.
80  bites reduced the likelihood of contracting Lyme borreliosis in humans.
81 haviors among all individuals diagnosed with Lyme borreliosis in inpatient and outpatient hospital co
82  defense against B. burgdorferi, we examined Lyme borreliosis in mice deficient in either caspase 1 o
83 eloped as a novel diagnostic test for active Lyme borreliosis in patients presenting disseminated per
84                   Individuals diagnosed with Lyme borreliosis in the hospital setting had an increase
85 to describe a novel Borrelia species causing Lyme borreliosis in the USA.
86                                              Lyme borreliosis in transgenic mice tolerant to Borrelia
87 Borrelia burgdorferi, the causative agent of Lyme borreliosis, in the central nervous system, only mi
88 esulting in extracutaneous manifestations of Lyme borreliosis, including Lyme neuroborreliosis.
89                                              Lyme borreliosis is a multisystemic disease caused by va
90                                              Lyme borreliosis is a tick-borne disease caused by the B
91                                              Lyme borreliosis is a tick-borne infectious disease that
92                                              Lyme borreliosis is caused by multiple species of the sp
93                                       Murine Lyme borreliosis is characterized by arthritis and cardi
94                                              Lyme borreliosis is prevalent throughout the Northern He
95                                              Lyme borreliosis is the most common tick-borne disease i
96                                              Lyme borreliosis is the most prevalent vector-borne dise
97                                              Lyme borreliosis is the object of numerous misconception
98 i sensu lato (s.l.), the tick-borne agent of Lyme borreliosis, is a bacterial species complex compris
99  the typical cutaneous manifestation of late Lyme borreliosis, is a chronic skin condition.
100 orferi sensu lato, the causative organism of Lyme borreliosis, is a heterogeneous group of spirochete
101 e characteristic skin manifestation of acute Lyme borreliosis, is a self-limited lesion.
102   Borrelia burgdorferi, a causative agent of Lyme borreliosis, is a zoonotic pathogen that survives i
103 rrelia burgdorferi, the etiological agent of Lyme borreliosis, is that persistent infection is the ru
104                  Lyme disease, also known as Lyme borreliosis, is the most common tick-transmitted di
105 he thyX gene for thymidylate synthase of the Lyme borreliosis (LB) agent Borrelia burgdorferi is loca
106 elia spirochetes are the causative agents of Lyme borreliosis (LB) and relapsing fever (RF).
107    Human granulocytic ehrlichiosis (HGE) and Lyme borreliosis (LB) are acquired after Ixodes ricinus-
108 patients with chronic symptoms attributed to Lyme borreliosis (LB) have LB or another disease.
109                            In North America, Lyme borreliosis (LB) is a tick-borne disease caused by
110             Laboratory confirmation of early Lyme borreliosis (LB) is challenging.
111                             The diagnosis of Lyme borreliosis (LB) is commonly made by serologic test
112                                              Lyme borreliosis (LB) is the archetypal emerging zoonosi
113                                        Human Lyme borreliosis (LB) is the most prevalent arthropod-bo
114 s (72.2%); other objective manifestations of Lyme borreliosis (LB) were present in 11 (7.6%).
115 mes need to evaluate a patient for suspected Lyme borreliosis (LB) who may have acquired the infectio
116 demic and much-debated tick-borne infection, Lyme borreliosis (LB), are unknown.
117 ers, such as depression, are associated with Lyme borreliosis (LB).
118 ated with sequences from 35 genomes of eight Lyme-borreliosis (LB) group Borrelia species and 7 Relap
119                                              Lyme borreliosis (Lyme disease) is often said to be asso
120  has not been studied using the experimental Lyme borreliosis model of infection of C3H mice with Bor
121 ogic testing also revealed possible cases of Lyme borreliosis (n = 142), babesiosis (n = 41), and HME
122 rom persons who had been diagnosed as having Lyme borreliosis on the basis of the presence of erythem
123                                              Lyme borreliosis, or Lyme disease (LD), is a tick-borne
124  with the development of neuroborreliosis in Lyme borreliosis patients in Europe.
125 cut off of two pathogen peptides, 9/10 acute Lyme Borreliosis patients resulted positive, while we id
126 ned after successful antibiotic treatment of Lyme borreliosis patients.
127        Borrelia burgdorferi, the pathogen of Lyme borreliosis, persists in nature through a tick-rode
128                Humans and other animals with Lyme borreliosis produce antibodies to a number of compo
129           Although tick immunity can prevent Lyme borreliosis, protection is not afforded against gra
130 ibodies, especially IgM antibodies, in early Lyme borreliosis sera provides additional evidence that
131                                        Early Lyme borreliosis sera with significant titers of anti-ou
132      In vivo studies using a murine model of Lyme borreliosis showed that while OspC F(ab)(2) fragmen
133 osts rather than tick species are the key to Lyme borreliosis spirochaete diversity.
134      In contrast to RF Borrelia species, the Lyme borreliosis spirochete Borrelia burgdorferi is amen
135 , suggesting that BptA may be widely used by Lyme borreliosis spirochetes for persistence in nature.
136 ith the concept of selective transmission of Lyme borreliosis spirochetes.
137                      The causative agents of Lyme borreliosis, spirochetes belonging to the Borrelia
138 ntinue to be misattributed to nervous system Lyme borreliosis, supported by, at best, limited evidenc
139  Borrelia burgdorferi spirochetes that cause Lyme borreliosis survive for a long time in human serum
140 Experts disagree on the significance of post-Lyme borreliosis symptoms.
141 ocytoma is a rare cutaneous manifestation of Lyme borreliosis that has been reported almost exclusive
142                                    In murine Lyme borreliosis, the absence of gamma delta T lymphocyt
143                        In the mouse model of Lyme borreliosis, the host immune response during infect
144  present studies, we use the murine model of Lyme borreliosis to define an OspA T cell epitope locate
145 es of sera from patients with early or later Lyme borreliosis to the antibody reactivities of sera fr
146                                A recombinant Lyme borreliosis vaccine consisting of outer surface pro
147   Twelve of 15 patients (80%) with suspected Lyme borreliosis, versus 0 of 10 controls, were positive
148              Having more than one episode of Lyme borreliosis was associated with increased incidence
149 equence of Borrelia burgdorferi, an agent of Lyme borreliosis, was used to study the genetic content
150 intravital microscopy and the mouse model of Lyme borreliosis, we observed that Borrelia burgdorferi
151 rain to use for the development of a generic Lyme borreliosis Western blot for Europe.
152  protective immunogen in the murine model of Lyme borreliosis when mice were challenged (needle inocu
153                       These diseases include Lyme borreliosis, which is caused by Borrelia burgdorfer
154 i) in the upper midwestern USA, which causes Lyme borreliosis with unusually high spirochaetaemia.
155 Borrelia burgdorferi, the causative agent of Lyme borreliosis, with phagocytic cells induces the acti

 
Page Top